Treatment differences in pulmonary arterial hypertension management.
作者信息
Maron Bradley A, Ryan John J
机构信息
Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
University Hospital, University of Utah, Salt Lake City, Utah, USA.
出版信息
Pulm Circ. 2016 Dec;6(4):619. doi: 10.1086/688909.
Abstract
摘要
相似文献
1
Treatment differences in pulmonary arterial hypertension management.肺动脉高压治疗中的差异管理
Pulm Circ. 2016 Dec;6(4):619. doi: 10.1086/688909.
2
Pulse dose steroids in severe pulmonary arterial hypertension secondary to systemic lupus erythematosus.系统性红斑狼疮继发严重肺动脉高压时的脉冲剂量类固醇治疗
SAGE Open Med Case Rep. 2017 May 4;5:2050313X17707153. doi: 10.1177/2050313X17707153. eCollection 2017.
3
Uncertainties in the diagnosis and treatment of pulmonary arterial hypertension.肺动脉高压诊断与治疗中的不确定性
Circulation. 2008 Sep 9;118(11):1195-201. doi: 10.1161/CIRCULATIONAHA.106.674002.
4
Pulmonary Arterial Hypertension and Therapeutic Interventions.肺动脉高压与治疗干预
Int J Angiol. 2019 Jun;28(2):80-92. doi: 10.1055/s-0039-1692452. Epub 2019 Jun 28.
5
A review of prostaglandin analogs in the management of patients with pulmonary arterial hypertension.前列腺素类似物在肺动脉高压患者管理中的应用综述。
Respir Med. 2010 Jan;104(1):9-21. doi: 10.1016/j.rmed.2009.07.015. Epub 2009 Aug 15.
6
Evaluation and management of the patient with pulmonary arterial hypertension.肺动脉高压患者的评估与管理
Ann Intern Med. 2005 Aug 16;143(4):282-92. doi: 10.7326/0003-4819-143-4-200508160-00009.
7
Drug-Induced Pulmonary Arterial Hypertension: Mechanisms and Clinical Management.药物性肺动脉高压：机制与临床管理。
Cardiovasc Drugs Ther. 2019 Dec;33(6):725-738. doi: 10.1007/s10557-019-06920-x.
8
Pulmonary arterial hypertension in children: a medical update.儿童肺动脉高压：医学进展
Curr Opin Pediatr. 2008 Jun;20(3):288-93. doi: 10.1097/MOP.0b013e3282ff5fdc.
9
Management of patients with pulmonary arterial hypertension due to congenital heart disease: recent advances and future directions.先天性心脏病所致肺动脉高压患者的管理：最新进展与未来方向
Expert Rev Cardiovasc Ther. 2015 Dec;13(12):1377-92. doi: 10.1586/14779072.2015.1101341. Epub 2015 Oct 16.
10
Safety and tolerability of macitentan in the management of pulmonary arterial hypertension: an update.马昔腾坦治疗肺动脉高压的安全性和耐受性：最新进展
Drug Healthc Patient Saf. 2019 Sep 3;11:71-85. doi: 10.2147/DHPS.S173050. eCollection 2019.
引用本文的文献
1
Cardiac catheterization in pulmonary hypertension: doing it right, with a catheter on the left.肺动脉高压中的心脏导管插入术：正确操作，导管置于左侧。
Cardiovasc Diagn Ther. 2020 Oct;10(5):1718-1724. doi: 10.21037/cdt-20-483.
2
Atrial arrhythmias are associated with increased mortality in pulmonary arterial hypertension.房性心律失常与肺动脉高压患者死亡率增加相关。
Pulm Circ. 2018 Jul-Sep;8(3):2045894018790316. doi: 10.1177/2045894018790316. Epub 2018 Jul 3.
3
Epigenetics, inflammation and metabolism in right heart failure associated with pulmonary hypertension.与肺动脉高压相关的右心衰竭中的表观遗传学、炎症与代谢
Pulm Circ. 2017 Jul-Sep;7(3):572-587. doi: 10.1177/2045893217714463. Epub 2017 Jun 19.
本文引用的文献
1
An international physician survey of pulmonary arterial hypertension management.一项关于肺动脉高压管理的国际医生调查。
Pulm Circ. 2016 Sep;6(3):338-46. doi: 10.1086/688058.
2
The heterogeneity of clinical practice patterns among an international cohort of pulmonary arterial hypertension experts.一组国际肺动脉高压专家临床实践模式的异质性
Pulm Circ. 2014 Sep;4(3):441-51. doi: 10.1086/677357.
3
Clinical profile and underdiagnosis of pulmonary hypertension in US veteran patients.美国退伍军人患者的肺动脉高压临床特征和漏诊情况。
Circ Heart Fail. 2013 Sep 1;6(5):906-12. doi: 10.1161/CIRCHEARTFAILURE.112.000091. Epub 2013 Jun 27.
4
Expert consensus for performing right heart catheterisation for suspected pulmonary arterial hypertension in systemic sclerosis: a Delphi consensus study with cluster analysis.专家共识：对疑似系统性硬化症相关肺动脉高压进行右心导管检查：一项聚类分析德尔菲共识研究。
Ann Rheum Dis. 2014 Jan;73(1):191-7. doi: 10.1136/annrheumdis-2012-202567. Epub 2013 Jan 24.
5
Current practice for determining pulmonary capillary wedge pressure predisposes to serious errors in the classification of patients with pulmonary hypertension.目前用于确定肺毛细血管楔压的方法容易导致肺动脉高压患者分类出现严重错误。
Am Heart J. 2012 Apr;163(4):589-94. doi: 10.1016/j.ahj.2012.01.024.
6
Assessing response to therapy in idiopathic pulmonary arterial hypertension: a consensus survey of Canadian pulmonary hypertension physicians.评估特发性肺动脉高压治疗反应：加拿大肺动脉高压医生共识调查。
Can Respir J. 2011 Jul-Aug;18(4):230-4. doi: 10.1155/2011/510874.
7
Wide variation in clinicians' assessment of New York Heart Association/World Health Organization functional class in patients with pulmonary arterial hypertension.临床医生对肺动脉高压患者纽约心脏协会/世界卫生组织功能分级的评估存在很大差异。
Mayo Clin Proc. 2009 Jul;84(7):586-92. doi: 10.1016/S0025-6196(11)60747-7.
Zotero 插件